middle.news
Arovella’s second ALA-101 batch brings Phase 1 expansion closer
8:57am on Wednesday 7th of October, 2026 AEDT
•
Biotechnology
Read Story
Arovella’s second ALA-101 batch brings Phase 1 expansion closer
8:57am on Wednesday 7th of October, 2026 AEDT
Key Points
Second ALA-101 clinical batch released for patient use
Material expected to support dose escalation and initial dose expansion
Third batch targeted for release by the end of December
Epworth Hospital activated, with Sydney and Brisbane sites expected soon
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Arovella Therapeutics (ASX:ALA)
OPEN ARTICLE